Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 38777 San Mateo, CA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,720,125
+$598,725 QoQ
Shares Held
226,092
-1.7% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 354 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. ACAD ranks #92 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,771,839 $1,728,352,485
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,347,253 $1,662,680,977
3 ASND
Ascendis Pharma A/S
 1,862,503 $496,766,798
4 JAZZ
Jazz Pharmaceuticals plc
 2,040,250 $491,639,040
5 RVMD
Revolution Medicines, Inc.
 1,488,394 $278,746,426
6 INSM
INSMED Inc
 2,273,222 $242,370,927
7 LGND
Ligand Pharmaceuticals Inc
 752,044 $237,713,585
8 ARGX
Argenx SE
 224,930 $208,683,303

All Filings in ACAD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,720,125 226,092
2026-03-31 $5,121,400 230,072
2025-12-31 $4,580,308 171,483
2025-09-30 $8,076,847 378,484
2025-06-30 $3,348,545 155,241
2025-03-31 $2,869,076 172,732
2024-12-31 $3,318,926 180,868
2024-09-30 $2,906,280 188,965
2024-06-30 $3,074,369 189,192
2024-03-31 $2,745,412 148,481
2023-12-31 $1,578,178 50,405
2023-09-30 $1,033,703 49,602
2023-06-30 $1,135,324 47,404
2023-03-31 $580,144 30,826
2022-12-31 $498,789 31,331
2022-09-30 $519,708 31,767
2022-06-30 $211,800 15,032
2022-03-31 $438,768 18,116
2021-12-31 $390,898 16,748
2021-06-30 $17,358,630 711,711
2021-03-31 $18,309,330 709,664
2020-12-31 $37,979,694 710,432
2020-09-30 $29,279,456 709,805
2020-06-30 $32,794,317 676,590
2020-03-31 $28,585,927 676,590